Parkinson’s Tremor Can Improve Within Minutes With a Non-Invasive Brain Treatment

Imagine living for years with a hand that refuses to stay still.

Holding a cup requires concentration. Using a computer mouse becomes frustrating. Writing your name takes effort. A favorite hobby that once depended on steady hands slowly becomes almost impossible.

Then, during a single hospital procedure, the shaking suddenly becomes dramatically quieter.

That is what some people with tremor-dominant Parkinson’s disease have experienced after undergoing MRI-guided focused ultrasound, an advanced treatment that can target tiny areas deep inside the brain without opening the skull or implanting electrodes.

For 72-year-old Air Force veteran Bud Leavell, the change was striking.

Leavell had lived with Parkinson’s disease for years, and the tremor in his right hand had gradually interfered with everyday tasks and hobbies, including repairing antique radios. After undergoing focused ultrasound treatment, his troublesome tremor reportedly stopped during the procedure, allowing him to regain much of the control he had lost.

The result sounds almost unbelievable.

But the technology behind it has been studied for years—and research increasingly suggests that, for carefully selected Parkinson’s patients whose tremor no longer responds adequately to medication, focused ultrasound can provide substantial relief.

What Is MRI-Guided Focused Ultrasound?

MRI-guided focused ultrasound, often shortened to MRgFUS, combines two technologies.

MRI gives doctors extremely detailed images of the brain and allows them to identify a precise treatment target.

Focused ultrasound then directs hundreds of ultrasound beams through the skull toward that single location.

Individually, the beams carry relatively little energy.

But where they converge, they generate enough heat to create a tiny, carefully controlled lesion in brain tissue involved in abnormal movement signals.

There is no traditional surgical incision.

There is no opening of the skull.

And unlike deep brain stimulation, no electrical device needs to be permanently implanted.

The patient is typically awake during much of the procedure so doctors can repeatedly evaluate symptoms as the target is heated.

That allows them to observe changes in tremor almost in real time.

Why Can the Tremor Improve So Quickly?

Parkinson’s tremor is connected to abnormal signaling within complex movement circuits involving several parts of the brain.

For tremor-dominant disease, one target is an area of the thalamus called the ventral intermediate nucleus, or VIM.

By disrupting abnormal electrical signaling through this tiny region, focused ultrasound can reduce the circuit activity responsible for the tremor.

And because those signals are altered immediately, improvement does not necessarily require days or weeks.

During treatment, doctors may ask the patient to:

  • hold out a hand
  • draw a spiral
  • write
  • touch a target
  • drink from a cup

As progressively higher ultrasound energy is delivered, physicians can see whether the tremor begins to decrease.

That is why some of the most compelling videos of focused ultrasound show a shaking hand before treatment and a dramatically steadier hand just minutes later.

A randomized clinical trial published in JAMA Neurology found that treated patients with medication-resistant tremor-dominant Parkinson’s experienced substantially greater tremor improvement than patients who initially received a sham procedure.

Research Shows the Benefits Can Last

Immediate improvement is impressive, but the more important question is whether it persists.

Research suggests that meaningful tremor control can continue well beyond the day of treatment.

A prospective study involving 48 people with medication-refractory tremor-dominant Parkinson’s disease found significant tremor control at follow-up evaluations extending beyond one year in many participants.

Another study following 25 patients found significant improvement in tremor measurements 12 months after unilateral MR-guided focused ultrasound thalamotomy.

A 2026 systematic review and meta-analysis examining 16 studies likewise concluded that MRI-guided focused ultrasound significantly improved tremor scores in adults with tremor-dominant Parkinson’s disease, with benefits seen both in shorter-term and longer-term follow-up.

Those findings are encouraging, although individual responses vary.

Researchers Are Now Targeting More Than Tremor

Tremor is only one feature of Parkinson’s disease.

Other common motor symptoms include:

Bradykinesia: slowed movement

Rigidity: stiffness and resistance to movement

Postural instability: difficulty maintaining balance

Focused ultrasound research is therefore expanding beyond a single brain target.

Scientists have investigated targeting areas such as the pallidothalamic tract, which carries movement-related signals through the brain.

A more recent approach uses two targets during the same session: first the VIM for tremor, then the pallidothalamic tract for symptoms such as rigidity and slowed movement.

In a study of 20 patients with tremor-dominant Parkinson’s disease, researchers observed significant immediate improvements in tremor, rigidity and bradykinesia during dual-target treatment.

A smaller study following patients for one year also reported sustained improvements in tremor and motor symptoms following this dual-target approach.

This area remains under active investigation, but it illustrates how rapidly focused ultrasound technology is evolving.

How Is This Different From Deep Brain Stimulation?

For decades, deep brain stimulation (DBS) has been one of the most important surgical options for advanced Parkinson’s symptoms.

DBS involves surgically implanting electrodes in specific regions of the brain. These electrodes are connected to a pulse-generating device, usually implanted beneath the skin near the chest.

Electrical stimulation then modifies abnormal brain activity.

DBS has several advantages.

The stimulation can be adjusted over time, and treatment can often be tailored as symptoms change.

Focused ultrasound works differently.

Instead of implanting an electrical system, doctors create a permanent lesion within a targeted brain circuit.

There are therefore no wires, battery replacements or implanted hardware.

But the permanent nature of the lesion also means the treatment cannot simply be “turned down” or reprogrammed later.

Neither treatment is automatically better.

They are different tools that may suit different patients.

Focused Ultrasound Is Not a Cure for Parkinson’s

The dramatic disappearance of a tremor can understandably create headlines suggesting that Parkinson’s itself has vanished.

That is not what is happening.

Parkinson’s disease is a progressive neurological disorder involving the degeneration of dopamine-producing brain cells and changes across multiple neural systems.

Focused ultrasound does not reverse that underlying neurodegenerative process.

Instead, it targets specific abnormal movement circuits.

A patient may therefore experience dramatic relief from tremor while still having other Parkinson’s symptoms.

Medications may still be necessary.

The disease may continue progressing.

And symptoms affecting the untreated side of the body may remain.

That distinction is critical.

This is a symptom-targeted therapy, not a cure for the disease itself.

There Are Risks

“Non-invasive” does not mean risk-free.

Focused ultrasound deliberately alters brain tissue, and neurological side effects can occur.

Clinical studies have reported effects including:

  • temporary imbalance
  • numbness or altered sensation
  • weakness
  • difficulty with speech
  • changes in taste
  • gait problems

In one prospective Parkinson’s cohort, some patients experienced gait imbalance, sensory changes, weakness or speech-related effects after treatment, although reported adverse effects were generally classified as mild. Some persisted at later follow-up.

Research involving focused ultrasound for tremor more broadly has also documented persistent sensory or gait-related effects in a minority of patients.

Careful patient selection is therefore essential.

Who Might Be Considered?

Focused ultrasound is not intended for everyone with Parkinson’s disease.

It is particularly relevant to selected patients with tremor-dominant Parkinson’s whose tremor remains disabling despite optimized medication.

Doctors may consider factors such as:

  • which Parkinson’s symptom causes the greatest disability
  • whether symptoms predominantly affect one side
  • response to medications
  • age and overall medical condition
  • skull anatomy and bone density
  • previous neurological conditions
  • whether the patient is a suitable candidate for other procedures such as DBS

Brain imaging and specialist evaluation are required before treatment.

Why This Technology Is So Fascinating

Perhaps the most remarkable aspect of focused ultrasound is not simply that it can reduce tremor.

It is that doctors can reach a structure only a few millimeters wide deep inside the brain without making a traditional surgical incision.

MRI shows the target.

Ultrasound delivers the energy.

The patient provides immediate feedback.

And doctors can observe the neurological effect during the procedure itself.

It represents a completely different way of thinking about brain treatment: using precisely concentrated sound energy to alter circuits responsible for debilitating neurological symptoms.

A Glimpse Into the Future of Neurology

Focused ultrasound is being investigated for far more than Parkinson’s tremor.

Researchers are studying variations of the technology for essential tremor, other movement disorders and several neurological conditions.

Scientists are also investigating whether lower-energy ultrasound could temporarily open the blood-brain barrier, potentially allowing medicines to reach brain tissue more effectively.

Much of that research remains experimental.

But the larger direction is clear.

Neurology is steadily moving toward treatments capable of targeting increasingly precise structures and circuits within the living brain.

For patients whose hands have shaken uncontrollably for years, the most meaningful outcome may be much simpler.

Holding a cup again.

Writing clearly.

Using a screwdriver.

Repairing an old radio.

These seemingly ordinary actions can represent an enormous recovery of independence.

And for carefully selected people with tremor-dominant Parkinson’s disease, focused ultrasound is making some of those moments possible—sometimes within minutes.